Skip to main content

Table 2 Comparisons between HBsAg-seropositive and HBsAg-seronegative diabetic patients according to age and biochemical measurements

From: Molecular evaluation of hepatitis B virus infection and predominant mutations of pre-core, basal core promoter and S regions in an Iranian population with type 2 diabetes mellitus: a case–control study

  Means ± SD of all diabetic participants (733) Means ± SD of HBsAg negative subjects (705) Means ± SD of anti- HBsAg positive subjects (28) P-value
Age (year) 55.1937 ± 11.74690 55.0057 ± 11.65605 59.9286 ± 13.20474 0.03
FBS mg/dL 170.5730 ± 72.25192 171.1504 ± 72.59905 156.0357 ± 62.24770 0.28
Chol mg/dL 197.7640 ± 53.02186 198.3730 ± 53.09670 182.4286 ± 49.54566 0.12
TG mg/dL 192.2128 ± 86.48698 193.2610 ± 87.14868 165.8214 ± 63.32693 0.1
ALT IU/L 31.5375 ± 21.55816 31.2979 ± 21.29852 37.5714 ± 27.07114 0.13
AST IU/L 24.8554 ± 13.89916 24.7319 ± 13.90054 27.9643 ± 13.74498 0.23
  1. FBS fasting blood sugar; TG triglyceride; ALT alanine aminotransferase; AST aspartate aminotransferase; HBsAg hepatitis B surface antigen